Three clocks that must not be merged
A map of this cohort's analysis, not a recovery calendar. The cessation analysis and whole-cohort estimates have different starting points.
| Research time | What it was used for | Not a personal instruction |
|---|---|---|
| One year of follow-up | Classify stopped versus continued tobacco use | Not a year in which continued use is safe |
| The next four years | Compare amputation-free survival after classification | Not a guarantee against future amputation |
| Years since diagnosis | Separate overall-cohort survival estimates | Not years since quitting or a quitter-specific risk |
Which disease, and which outcome?
Buerger disease, also called thromboangiitis obliterans, is an inflammatory, nonatherosclerotic disease affecting vessels of the limbs. It is not simply another name for plaque-related peripheral arterial disease. Tobacco is strongly linked to it, and CDC and MedlinePlus emphasize stopping all tobacco—not just reducing cigarette numbers or replacing them with another tobacco product.
The useful research question is whether an amputation occurred during follow-up. ‘Amputation-free’ does not say that the person had no pain, healed every wound or needed no continuing care. Nor does a reduction in amputations prove regeneration of tissue already lost.
The study had a classification year, then an observation window
Le Joncour and colleagues reviewed 224 confirmed cases from French referral centres between 1970 and 2016. For the cessation comparison, people who had stopped by one year of follow-up were classified as ex-smokers. Smoking was checked by self-report at visits; people who reported restarting were classified as smokers. The comparison then examined the next four years of amputation-free survival, with a lower amputation risk in the stopped group (P=0.001).
The one-year point is a research classification, not permission to continue for a year. The four-year window is not a personal safety deadline. The study's separate 5-, 10- and 15-year estimates start at diagnosis for the overall cohort; they must not be labelled ‘years after quitting’ or presented as quitter-specific probabilities.
Why ‘90% were smokers’ does not mean ‘90% can avoid amputation’
Of 48 people recorded with a first amputation, 43 were current smokers and five were ex-smokers at that event—about 90% current smokers. The denominator is people who had an amputation, not all people who stopped or all who continued. That composition cannot calculate a 90% risk reduction, a success rate or a personal chance of keeping a limb.
This was a retrospective referral-centre cohort, not random allocation to tobacco withdrawal. Self-report, restarting, differences in severity and care, and the long historical span limit inference. Limb infection at diagnosis was also associated with amputation. That finding is a reason not to replace vascular care with a quit calendar; it is not an infection score readers can apply themselves.
Take the tobacco question back to the vascular team
With a confirmed diagnosis, ask how support for stopping tobacco fits into the existing specialist care, and what continuing follow-up remains necessary. Changes in limb pain, wounds or colour need clinical assessment rather than a claim that stopping has solved them. This page does not grade circulation or choose nicotine products, drugs or procedures. NHS services in England offer separate cessation support; confirm access locally and keep the vascular team involved. No tobacco history or wound information needs to be entered here.
What to keep in mind
Sources
The central claims on this page were checked against the sources below.
- Journal of the American Heart Association: Le Joncour et al. (2018): Long-Term Outcome and Prognostic Factors in Buerger disease; 224-patient cohort, smoking-status methods and Figure 3 discussion
Sources checked: 2026-10-08
- CDC: Smoking and Buerger’s Disease
Sources checked: 2026-10-08
- U.S. National Library of Medicine / MedlinePlus: Thromboangiitis obliterans
Sources checked: 2026-10-08
- NHS: England: local stop-smoking support
Sources checked: 2026-10-08
General study interpretation, not diagnosis of Buerger disease, an individual limb prognosis, wound or circulation assessment, or tobacco-product, medication or procedure selection.